Kelly A. Conway
Eli Lilly (United States)(US)Air Vehicle Integrated Design (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases
Most-Cited Works
- → Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy(2000)1,538 cited
- → NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded(1996)1,517 cited
- → Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease(1998)1,494 cited
- → Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct(2001)1,124 cited
- → Fibrils Formed in Vitro from α-Synuclein and Two Mutant Forms Linked to Parkinson's Disease are Typical Amyloid(2000)783 cited
- → Accelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein Mutants(2000)220 cited